g.haaland
TL3 Regular · Poznań, PL
Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.
Joined 13 November 2024 · last posted 4d · groups: analytical-chemists, translators
159 posts, newest first. Showing up to 150.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #105 · Start Here › Welcome · 24 Jul 2026 · 0 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #68 · Clinical › Prescriber conversations · 23 Jul 2026 · 0 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
Transit times by route, from a logged dataset Replied, post #22 · Sourcing › Logistics · 20 Jul 2026 · 0 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Submitting a sample: the process end to end Replied, post #91 · Sourcing › Independent verification · 18 Jul 2026 · 13 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #5 · Compounds › Oral incretins · 17 Jul 2026 · 3 likes I read post #3 twice before replying, because I had assumed the opposite. Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #92 · Compounds › Repair & healing peptides · 16 Jul 2026 · 0 likes post #91 answers the question as asked. The question underneath it is different. What would change the position on repair peptides: adequately powered, published,…
-
Prescription portability between countries Replied, post #100 · Access › International · 15 Jul 2026 · 26 likes Coming back to post #98, because the follow-up matters more than the original answer. Customs and import outcomes: different routes have different seizure rates. Some…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #25 · Evidence › Preprints · 15 Jul 2026 · 3 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #66 · Practice › Dosing & titration · 15 Jul 2026 · 2 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #58 · Outcomes › Body composition · 14 Jul 2026 · 22 likes On post #54 — agreed on the reasoning, with one qualification. Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #85 · Practice › Interactions · 14 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #38 · Start Here › Welcome · 13 Jul 2026 · 3 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
What to include when your question involves a chromatogram — one year on Replied, post #74 · Start Here › How to Ask · 12 Jul 2026 · 0 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Priming a pen and whether the primed volume is wasted Replied, post #2 · Devices › Pens & autoinjectors · 11 Jul 2026 · 6 likes the opening post answers the question as asked. The question underneath it is different. Pen confusion between compounds: if you are using multiple pens or alternating…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #12 · Start Here › How to Ask · 10 Jul 2026 · 2 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #76 · Sourcing › Red flags · 6 Jul 2026 · 0 likes On post #72 — agreed on the reasoning, with one qualification. Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #5 · Access › Insurance & coverage · 6 Jul 2026 · 25 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #50 · Analytics › Impurities & related substances · 5 Jul 2026 · 26 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #12 · Practice › Side effects · 29 Jun 2026 · 3 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Journal club: what we got wrong in an earlier session Replied, post #32 · Evidence › Journal club · 27 Jun 2026 · 0 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Electrolyte supplements: which ones do anything Replied, post #40 · Nutrition & Training › Hydration & electrolytes · 26 Jun 2026 · 4 likes This follows post #37 rather than contradicting it. Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #45 · Clinical › Bloodwork · 17 Jun 2026 · 21 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #73 · Compounds › Repair & healing peptides · 16 Jun 2026 · 9 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
-
Asking a follow-up: new topic or new reply? Replied, post #5 · Start Here › How to Ask · 9 Jun 2026 · 0 likes post #4 is right about the mechanism and I think understates the practical bit. Asking a follow-up: new topic or reply in the old one? If the answer depends on the…
-
Tracking a shortage from primary sources rather than rumour Replied, post #33 · Access › Shortages · 2 Jun 2026 · 28 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #67 · Practice › Storage & stability · 31 May 2026 · 24 likes post #66 is right about the mechanism and I think understates the practical bit. Protecting from light: amber vials or opaque containers reduce light exposure. If you…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #52 · Safety › Contraindications · 27 May 2026 · 12 likes Picking up post #49: that is the part I would want checked first. Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential…
-
A fridge failure and how I assessed the contents afterwards Replied, post #11 · Devices › Cold chain · 21 May 2026 · 2 likes post #10 is right about the mechanism and I think understates the practical bit. Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque…
-
Prescription requirements and telehealth models — a second dataset Replied, post #34 · Sourcing › Regulatory · 18 May 2026 · 9 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
The headache that turns out to be dehydration — the long version Replied, post #35 · Nutrition & Training › Hydration & electrolytes · 14 May 2026 · 31 likes Coming back to post #33, because the follow-up matters more than the original answer. Water intoxication: drinking excessive water (more than a few liters per day for…
-
Travelling with an injectable: documentation and practicalities Replied, post #27 · Access › International · 14 May 2026 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #2 · Compounds › Oral incretins · 13 May 2026 · 0 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
Reading a trial's population section before its results Replied, post #15 · Evidence › Trials · 12 May 2026 · 26 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #5 · Start Here › How to Ask · 8 May 2026 · 2 likes I read post #3 twice before replying, because I had assumed the opposite. Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous…
-
Revisiting: Absolute versus relative contraindications Replied, post #82 · Safety › Contraindications · 4 May 2026 · 3 likes Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current evidence is mixed. The risk is not zero and some caution is appropriate in people…
-
Official shortage notices and what they authorise Replied, post #30 · Access › Shortages · 2 May 2026 · 0 likes Coming back to post #28, because the follow-up matters more than the original answer. Allocation and rationing: during severe shortages, suppliers might ration…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #23 · Analytics › COA interpretation · 2 May 2026 · 4 likes Coming back to post #21, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Why 99.2% and 97.8% on the same lot can both be correct Started this topic · Analytics › HPLC & UHPLC · 22 Apr 2026 · 44 likes Why 99.2% and 97.8% on the same lot can both be correct I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to…
-
List price versus negotiated price versus what you pay Replied, post #37 · Access › Pricing · 11 Apr 2026 · 13 likes Worth separating two things that post #33 runs together. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #78 · Clinical › Bloodwork · 10 Apr 2026 · 17 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
Spike-and-recover accuracy for a peptide assay Replied, post #70 · Analytics › Method validation · 9 Apr 2026 · 22 likes I read post #68 twice before replying, because I had assumed the opposite. System suitability: injections run at the start of a batch to establish that the instrument…
-
Follow-up: State-level differences that actually matter Replied, post #32 · Regional › North America · 5 Apr 2026 · 30 likes Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician reviewing measurements and history are not recommended by this community.
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Started this topic · Analytics › Impurities & related substances · 3 Apr 2026 · 23 likes Second pass at: Where impurities in solid-phase peptide synthesis come from Writing it up because I had to work it out twice and would rather nobody else did. A…
-
Reading U-100 graduations, with a conversion table Replied, post #19 · Devices › Syringes & needles · 1 Apr 2026 · 0 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #84 · Pharmacology › Pharmacokinetics · 27 Mar 2026 · 1 like SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Replied, post #11 · Data & Tools › Datasets · 23 Mar 2026 · 9 likes Combining data from different sources: datasets from this site are not directly comparable to published trials because the populations are different. They are worth…
-
Publication bias detection and its low power — does this still hold? Replied, post #18 · Evidence › Meta-analyses · 18 Mar 2026 · 7 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #104 · Clinical › Bloodwork · 18 Mar 2026 · 0 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Grapefruit: why this class is not the class that cares Replied, post #37 · Practice › Interactions · 13 Mar 2026 · 2 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Contributing data without breaching anyone's privacy Replied, post #65 · Data & Tools › Datasets · 6 Mar 2026 · 0 likes How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset.
-
What a certificate commits its issuer to — one year on Replied, post #26 · Analytics › COA interpretation · 3 Mar 2026 · 14 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Choosing which test to pay for, given a fixed budget Replied, post #12 · Sourcing › Independent verification · 3 Mar 2026 · 28 likes post #11 answers the question as asked. The question underneath it is different. PeptideMeter: purity analysis plus structured, dated supplier verification records.…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #133 · Compounds › Semaglutide · 2 Mar 2026 · 6 likes On post #129 — agreed on the reasoning, with one qualification. On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #21 · Compounds › Tirzepatide · 20 Feb 2026 · 0 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #89 · Practice › Dosing & titration · 19 Feb 2026 · 27 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reading U-100 graduations, with a conversion table — one year on Replied, post #4 · Devices › Syringes & needles · 10 Feb 2026 · 0 likes This follows post #3 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
[2026 update] Long-time reader, first-time poster Replied, post #49 · Lounge › Introductions · 9 Feb 2026 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #65 · Meta › Site feedback · 7 Feb 2026 · 0 likes Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what you did, what you expected, what happened instead) so…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #89 · Access › International · 3 Feb 2026 · 0 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #58 · Meta › Site feedback · 30 Jan 2026 · 13 likes Coming back to post #56, because the follow-up matters more than the original answer. Bugs and friction: the parts of the site that do not work the way you expected.…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #71 · Practice › Side effects · 19 Jan 2026 · 0 likes Picking up post #68: that is the part I would want checked first. Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have…
-
Aggregates and why a purity assay may miss them entirely Replied, post #61 · Analytics › Impurities & related substances · 9 Jan 2026 · 17 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Preprint servers and what screening they do Replied, post #19 · Evidence › Preprints · 8 Jan 2026 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #55 · Practice › Side effects · 8 Jan 2026 · 32 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Micro-titration: a disputed topic, argued properly Replied, post #20 · Practice › Dosing & titration · 8 Jan 2026 · 13 likes On post #16 — agreed on the reasoning, with one qualification. Reaching a dose and staying there for a year: the question of whether a stable dose remains effective…
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #19 · Compounds › Oral incretins · 2 Jan 2026 · 20 likes Worth separating two things that post #15 runs together. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #124 · Compounds › Oral incretins · 2 Jan 2026 · 4 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #26 · Start Here › Welcome · 31 Dec 2025 · 6 likes post #25 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Reverse causation in a cohort study of weight and outcome Replied, post #10 · Evidence › Study critique · 31 Dec 2025 · 7 likes I read post #8 twice before replying, because I had assumed the opposite. Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true…
-
CJC-1295 with and without DAC: what the modification does — what changed since Replied, post #4 · Compounds › Secretagogues & GH axis · 26 Dec 2025 · 12 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
The decimal-point error, and the habit that catches it Replied, post #106 · Practice › Reconstitution · 18 Dec 2025 · 8 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Realistic expectations for strength while losing weight quickly Replied, post #45 · Nutrition & Training › Resistance training · 17 Dec 2025 · 15 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #74 · Compounds › Oral incretins · 16 Dec 2025 · 0 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Tracking a preprint to publication: a worked example Replied, post #123 · Evidence › Preprints · 12 Dec 2025 · 0 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
Personal import allowances, compared — a second dataset Replied, post #32 · Access › International · 6 Dec 2025 · 8 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Tracking a preprint to publication: a worked example Replied, post #39 · Evidence › Preprints · 3 Dec 2025 · 2 likes Picking up post #36: that is the part I would want checked first. Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes…
-
Pen dose counters: what a click does and does not guarantee Replied, post #75 · Devices › Pens & autoinjectors · 17 Nov 2025 · 1 like Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #135 · Practice › Storage & stability · 12 Nov 2025 · 0 likes On post #131 — agreed on the reasoning, with one qualification. Published stability data applies specifically to the formulation studied, under the specific conditions…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #77 · Analytics › HPLC & UHPLC · 6 Nov 2025 · 8 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
[2026 update] What steady state means for the decision to escalate Replied, post #12 · Practice › Dosing & titration · 5 Nov 2025 · 2 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Coverage in the US: a map of the usual obstacles Replied, post #7 · Regional › North America · 3 Nov 2025 · 0 likes Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are prescription-only. Coverage varies between public and private insurance.
-
How to read a forest plot, properly, from scratch Replied, post #47 · Evidence › Trials · 28 Oct 2025 · 32 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #108 · Practice › Storage & stability · 28 Oct 2025 · 32 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #121 · Compounds › Tirzepatide · 24 Oct 2025 · 0 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #100 · Compounds › Tirzepatide · 23 Oct 2025 · 0 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
A payment that went through twice: how it was resolved Replied, post #6 · marked as the solution · Sourcing › Payments · 17 Oct 2025 · 7 likes Bank transfer and finality: once a bank transfer is sent, it is final. The money is gone. There is no recourse with the bank if the supplier disappears. That is why…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #4 · Outcomes › Body composition · 9 Oct 2025 · 24 likes the opening post is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct…
-
MHRA statements, read directly Replied, post #12 · Regional › UK & Ireland · 6 Oct 2025 · 29 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #63 · Compounds › Other compounds · 4 Oct 2025 · 17 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #49 · Compounds › Repair & healing peptides · 29 Sep 2025 · 0 likes Worth separating two things that post #45 runs together. The absence of adequately powered published randomised human trials is the central fact about BPC-157. This…
-
Payment method and the leverage it gives you, ranked Replied, post #24 · Sourcing › Payments · 17 Sep 2025 · 9 likes Worth separating two things that post #20 runs together. Cryptocurrency for payment: offers less fraud protection than credit cards and is final like bank transfer.…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #116 · Evidence › Study critique · 16 Sep 2025 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
MHRA statements, read directly Replied, post #3 · Regional › UK & Ireland · 13 Sep 2025 · 1 like Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #120 · Practice › Reconstitution · 6 Sep 2025 · 1 like The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #106 · Compounds › Secretagogues & GH axis · 27 Aug 2025 · 8 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #45 · Practice › Side effects · 21 Aug 2025 · 0 likes I read post #43 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #85 · Compounds › Oral incretins · 19 Aug 2025 · 23 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Publishing an inconvenient result: a case study Replied, post #63 · Sourcing › Independent verification · 9 Aug 2025 · 21 likes This follows post #60 rather than contradicting it. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual…
-
Tracking that stops updating and then resumes Replied, post #16 · Sourcing › Logistics · 8 Aug 2025 · 29 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Realistic expectations for strength while losing weight quickly Replied, post #12 · Nutrition & Training › Resistance training · 6 Aug 2025 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Are there stupid questions here? A staff answer, at length Replied, post #42 · Start Here › Welcome · 5 Aug 2025 · 23 likes Picking up post #39: that is the part I would want checked first. Welcome. The orientation materials are pinned at the top of this category and they take about an hour.…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #35 · Compounds › Retatrutide · 4 Aug 2025 · 10 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #20 · Practice › Dosing & titration · 2 Aug 2025 · 11 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Travel coolers and how long they really hold Replied, post #23 · Devices › Cold chain · 2 Aug 2025 · 8 likes This follows post #20 rather than contradicting it. Travel with medication: carrying a vial across borders requires planning if temperatures will exceed the range or if…
-
Travel coolers and how long they really hold Replied, post #12 · Devices › Cold chain · 31 Jul 2025 · 0 likes post #11 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
How to research a compound with no human data without deceiving yourself Replied, post #15 · Compounds › Other compounds · 30 Jul 2025 · 0 likes Worth separating two things that post #11 runs together. This subcategory exists because some people will research compounds outside the main groups discussed here. The…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #32 · Compounds › Semaglutide · 25 Jul 2025 · 25 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #2 · Compounds › Secretagogues & GH axis · 20 Jul 2025 · 0 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #38 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2025 · 3 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #58 · Evidence › Journal club · 28 Jun 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
What a documentation review can and cannot tell you Replied, post #10 · Sourcing › Independent verification · 20 Jun 2025 · 11 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #19 · Analytics › Method validation · 19 Jun 2025 · 0 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
Regression to the mean in progress reports Replied, post #21 · Research Methods › Statistics · 16 Jun 2025 · 5 likes post #20 answers the question as asked. The question underneath it is different. Relative risk and odds ratios: both compare the rate in one group to the rate in…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #123 · Data & Tools › Calculators · 9 Jun 2025 · 14 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #130 · Compounds › Cagrilintide & amylin analogues · 8 Jun 2025 · 0 likes On post #126 — agreed on the reasoning, with one qualification. Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #3 · Compounds › Tirzepatide · 7 Jun 2025 · 19 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Preparing for an appointment: one page, three questions Replied, post #21 · Clinical › Prescriber conversations · 2 Jun 2025 · 5 likes This follows post #18 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
An emergency department visit, described afterwards Replied, post #25 · Safety › Adverse events · 28 May 2025 · 0 likes Worth separating two things that post #21 runs together. Where to report: in many countries there is a pharmacovigilance system where adverse events can be reported.…
-
Albumin binding and how it produces a long half-life Replied, post #41 · Pharmacology › Pharmacokinetics · 27 May 2025 · 0 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #48 · Practice › Storage & stability · 24 May 2025 · 3 likes This follows post #45 rather than contradicting it. Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast…
-
A well-designed study with a badly written abstract Replied, post #66 · Evidence › Study critique · 7 May 2025 · 14 likes Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
-
Coverage for the indication versus for the drug Replied, post #52 · Access › Insurance & coverage · 4 May 2025 · 8 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
A ten-fold dose error caught before injection Replied, post #29 · Devices › Syringes & needles · 3 May 2025 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #82 · Sourcing › Red flags · 18 Apr 2025 · 3 likes Worth separating two things that post #78 runs together. Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from…
-
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #3 · Analytics › HPLC & UHPLC · 8 Apr 2025 · 33 likes Picking up post #2: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #56 · Access › Pricing · 6 Apr 2025 · 8 likes Worth separating two things that post #52 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
A certificate with no method stated: what can you conclude? Replied, post #28 · Analytics › COA interpretation · 4 Apr 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Requesting a page: what makes a good request Replied, post #32 · Documentation › Wiki requests · 23 Mar 2025 · 2 likes Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the maintainers prioritise multilingual work.
-
Counter-ion content and its effect on measured mass Replied, post #4 · Analytics › Mass spectrometry · 22 Mar 2025 · 0 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #8 · Sourcing › Vendor reports · 14 Mar 2025 · 0 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #25 · Compounds › Tirzepatide · 14 Mar 2025 · 16 likes Coming back to post #23, because the follow-up matters more than the original answer. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on…
-
An emergency department visit, described afterwards Replied, post #2 · Safety › Adverse events · 5 Mar 2025 · 24 likes Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine elevation) warrant urgent evaluation. Severe dehydration during weight loss is a…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #119 · Compounds › Semaglutide · 2 Mar 2025 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #4 · Evidence › Journal club · 26 Feb 2025 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Reading order for a first week here, and what to skip until later Replied, post #5 · Start Here › Welcome · 14 Feb 2025 · 28 likes On the opening post — agreed on the reasoning, with one qualification. On the reading order question specifically: start with the how-to-ask materials in this category,…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #9 · Compounds › Tirzepatide · 23 Jan 2025 · 17 likes I read post #7 twice before replying, because I had assumed the opposite. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #8 · Compounds › Repair & healing peptides · 22 Jan 2025 · 0 likes On post #4 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #19 · Practice › Interactions · 21 Jan 2025 · 0 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
What we do not know about retatrutide, listed explicitly Replied, post #63 · Compounds › Retatrutide · 20 Jan 2025 · 6 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
[2026 update] New subcategory: rationale and scope Replied, post #136 · Meta › Announcements · 10 Jan 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #11 · Pharmacology › Receptor biology · 25 Dec 2024 · 0 likes Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and downstream effects over years of exposure to these…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #14 · Practice › Reconstitution · 24 Dec 2024 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #13 · Data & Tools › Calculators · 7 Dec 2024 · 32 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Washout with a one-week half-life: the arithmetic Replied, post #73 · Research Methods › N-of-1 designs · 5 Dec 2024 · 25 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
-
Reading a supplementary appendix and finding the interesting part Replied, post #35 · Evidence › Trials · 2 Dec 2024 · 27 likes post #34 answers the question as asked. The question underneath it is different. Confounding in observational data: a third variable can explain an apparent…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #46 · Compounds › Tirzepatide · 20 Nov 2024 · 17 likes Picking up post #43: that is the part I would want checked first. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #30 · Compounds › Repair & healing peptides · 11 Nov 2024 · 0 likes On post #26 — agreed on the reasoning, with one qualification. For anyone arriving from search engines: this subcategory discusses published preclinical work and the…
-
Blind submission and why it changes minds Replied, post #94 · Sourcing › Independent verification · 21 Oct 2024 · 0 likes On post #90 — agreed on the reasoning, with one qualification. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #27 · Compounds › Semaglutide · 17 Oct 2024 · 0 likes post #26 is right about the mechanism and I think understates the practical bit. Approved indications differ by jurisdiction and change. As of mid-2026 the…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #50 · Compounds › Semaglutide · 13 Sep 2024 · 5 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…